Last updated: April 13, 2023
Sponsor: Capital Medical University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Thrombosis
Treatment
N/AClinical Study ID
NCT05413837
CVSAV-HI
Ages 18-35 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age 18 - 35 years old.
- Confirmed no intracranial diseases, congenital abnormalities such as intracranialhematoma, tumor, vascular malformation, hydrocephalus, etc.
- Voluntarily signed informed consent.
Exclusion
Exclusion Criteria:
- Any clinical history, including hypertension, diabetes, coronary heart disease,hematologic and rheumatic immune system diseases,cervical spondylosis, anxiety,depression, insomnia, etc.
- Internal jugular venous outflow disturbance : MRV from extracranial to aortic archdemonstrates variation or stenosis of the internal jugular vein, vertebral plexus,brachiocephalic vein, and superior vena cava.
- Any history of craniocerebral trauma or surgery that affected the existence andrunning of veins.Unhealthy habits such as smoking, heavy drinking, etc.
- Women who are pregnant or in preparation for pregnancy or lactation.
- Other conditions that the researchers considered might affect the trial andinappropriate for inclusion.
Study Design
Total Participants: 40
Study Start date:
July 06, 2022
Estimated Completion Date:
August 31, 2023
Study Description
Connect with a study center
Xuanwu hospital;Capital Medical University
Beijin, XI Cheng District 100053
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.